Functional testing: ACEI renography

Seminars in Nephrology

Volumn 20, Issue 5, 2000, Pages 437-444

  Taylor, A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT;

AGED; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; RENOGRAPHY; RENOVASCULAR HYPERTENSION; REVASCULARIZATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; COSTS AND COST ANALYSIS; ENALAPRILAT; HUMANS; HYPERTENSION, RENOVASCULAR; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; RENAL ARTERY OBSTRUCTION; SENSITIVITY AND SPECIFICITY;

EID: 0033811702     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Renal artery stenosis: A clinical-pathologic study in normotensive and hypertensive patients
2. Influence of valsartan on renographic pattern in RVH is different to captopril
3. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects
4. The effect of bradykinin on proximal tubular sodium reabsorption in the dog: Evidence for functional nephron heterogeneity
5. Technetium-99m (99m Tc) mercaptoacetyltriglycine: Update on the new 99m Tc renal tubular function agent
6. 3 in humans
7. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique
8. Normal parameters for Tc-99m MAG3 renography
9. Renal artery stenosis and ischemia: Effect on renal blood flow and extraction fraction
10. The true clinical significance of renography in nephro-urology
11. Consensus report on ACE inhibitor renography for detecting renovascular hypertension
12. Prospective study of simultaneous orthoiodohipurate and diethylenetriaminepentaacetic acid captopril renography
13. Diagnosis of renovascular hypertension with ACE inhibition scintigraphy
14. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422
15. Furosemide I-131 hipppuran renography after angiotensin-converting enzyme inhibition for the diagnosis of renovascular hypertension
16. Enalaprilat-enhanced renography in a rat model of renovascular hypertension
17. Report of the working party group for patient selection and preparation
18. Angiotensin-converting enzyme inhibition-induced changes in hippurate renography and renal function in renovascular hypertension
19. Simplified captopril renography in diagnosis and treatment of renal artery stenosis
20. Effect of chronic ACE inhibition on the diagnostic value of renography for renovascular hypertension: A preliminary report
21. Radionuclide renography: A personal approach
22. Technetium-99m-MAG3 renal studies: Normal range and reproducibility of physiologic parameters as a function of age and sex
23. Diagnostic criteria of renovascular hypertension with captopril renography
24. Multicentre Study Group Institute of Clinical Physiology, Hypertension Unit, University of Pisa, Italy. Detection of renovascular hypertension by captorpil renography with MAG3: A multicentre study
25. Screening for renovascular hypertension in a population with relatively low prevalence
26. Comparison of two noninvasive screening test for renovascular hypertension
27. The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience
28. Captopril radionuclide test in renovascular hypertension: A European multicentre study
29. Captopril-enhanced Tc-99m MAG3 renal scintigraphy in subjects with suspected renovascular hypertension
30. Role of captopril renography in the diagnosis of renovascular hypertension
31. Prognostic value of captopril renal scintigraphy in renovascular hypertension
32. Captopril radionuclide test in renovascular hypertension: European multicenter study
33. Simplified captopril renography in diagnosis and treatment of renal artery stenosis
34. Captopril renography and the effect of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis
35. Bilateral symmetrical induced changes in captopril scintigraphy
36. Renovascular hypertension with low to normal plasma renin: Clinical and angiographic features
37. Comparative costs of diagnostic procedures, in Taylor A, Schuster D, Alazaraki N: A Clinician's Guide to Nuclear Imaging and Therapy. Reston, VA, Society of Nuclear Medicine (in press)
38. A prospective evaluation of a simplified captoptil test for the detection of renovascular hypertension
39. The captopril test for identifying renovascular disease in hypertensive patients
40. Renal vein renins: Inability to predict response to revascularization in patients with hypertension
41. The diagnosis of renovascular hypertension: The role of captopril renal scintigraphy and related issues
42. Treatment of renovascular disease and of renovascular hypertension
43. The acute humoral and hemodynamic response to ACE inhibition does not discriminate renovascular from essential hypertensives
44. Cost efficacy of the diagnosis and therapy of renovascular hypertension
45. Captopril test: Time over?
46. The significance of captopril renography in renovascular hypertension
47. Captopril renography in the diagnosis of renal artery stenosis: Accuracy and limitations
48. Prospective study on captopril renography in hypertensive patients
49. Reliability of Ace inhibitor-enhanced Tc-99m DTPA gamma camera renography in the detection of renovascular hypertension
50. Captoril renal scintigraphy: A new standard for predicting outcome after renal revascularization